| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $141,111,481 ) (Continued on the next page) |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HD117584 | Microbiome-induced changes following influenza infection during pregnancy | 001 | 1 | NIH | 12/5/2024 | -$74,764 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HD117584 | Microbiome-induced changes following influenza infection during pregnancy | 001 | 1 | NIH | 12/5/2024 | $74,764 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HD117584 | Microbiome-induced changes following influenza infection during pregnancy | 002 | 1 | NIH | 12/5/2024 | $0 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F32HD117584 | Microbiome-induced changes following influenza infection during pregnancy | 000 | 1 | NIH | 11/7/2024 | $74,764 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01AI182234 | Chemosensory Mechanisms Driving Malaria Transmission | 000 | 1 | NIH | 11/15/2024 | $707,696 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156374 | Computational Methods to Characterize Alternative Splicing and Genetic Determinants from Heterogeneous Sequence Data | 000 | 1 | NIH | 12/24/2024 | $363,392 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U24NS129499 | Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 001 | 3 | NIH | 2/17/2025 | $183,360 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U24NS129499 | Network for Emergency Care Clinical Trials: Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) | 001 | 3 | NIH | 2/17/2025 | $177,789 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01NS074324 | Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD | 000 | 15 | NIH | 2/20/2025 | $374,021 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01NS074324 | Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD | 000 | 15 | NIH | 2/20/2025 | $14,114 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01NS074324 | Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD | 000 | 15 | NIH | 2/20/2025 | $82,331 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K08AI174959 | Mechanisms of a therapeutic DNA vaccine targeting Mycobacterium tuberculosis persisters | 000 | 2 | NIH | 11/12/2024 | $200,880 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI183329 | The antigenic origin of anti-dsDNA antibodies in SLE | 000 | 2 | NIH | 12/13/2024 | $198,547 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI182032 | Clinical Research Unit: Johns Hopkins University | 000 | 2 | NIH | 2/12/2025 | $390,000 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | U01AI168287 | Solving Opportunities for Spillover (SOS): Frequency and Mechanisms of Cross-species Transmission of Henipaviruses in Bangladesh | 000 | 3 | NIH | 12/11/2024 | $630,197 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 001 | 19 | NIH | 2/12/2025 | $1,416,706 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 001 | 19 | NIH | 2/12/2025 | $2,261,628 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 001 | 19 | NIH | 2/12/2025 | $258,476 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $1,416,707 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $657,416 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $2,261,629 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | UM1AI068613 | LC: HIV PREVENTION TRIALS NETWORK | 000 | 19 | NIH | 11/22/2024 | $258,476 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA296410 | Optimization of an active mutant KRAS peptide vaccine in colorectal cancer | 000 | 1 | NIH | 12/30/2024 | $589,838 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21EB035675 | Metal Fluorination For biomolecules: Expanding The Radiofluorination Toolbox | 000 | 1 | NIH | 12/5/2024 | $174,375 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31GM157915 | Mapping Tight Junction Architecture | 000 | 1 | NIH | 12/11/2024 | $48,974 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | G13LM014707 | Around the clock: Time in medieval Islamic clinical cultures | 000 | 1 | NIH | 12/20/2024 | $91,049 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31EY037190 | The development and connectivity of starburst amacrine cells in human retinal organoids | 001 | 1 | NIH | 12/13/2024 | $0 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31EY037190 | The development and connectivity of starburst amacrine cells in human retinal organoids | 000 | 1 | NIH | 12/13/2024 | $48,974 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI188223 | Targeting a reductive dehalogenase as a new strategy for controlling mosquito populations | 000 | 1 | NIH | 11/12/2024 | $211,038 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | K24AI185302 | Advancing Mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria | 000 | 1 | NIH | 1/24/2025 | $212,169 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156916 | Gene regulatory networks for hair cell regeneration | 000 | 1 | NIH | 12/23/2024 | $387,500 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA300052 | Engineering self-propelled tumor-infiltrating CAR T cells using synthetic velocity receptors | 000 | 1 | NIH | 2/24/2025 | $627,272 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R34MH133617 | The Caregiver-Informed Treatment Engagement (CITE) Program: a Pilot Trial of a Treatment Engagement Intervention for Historically Underserved Youth | 000 | 1 | NIH | 2/21/2025 | $242,795 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156470 | Exploring new approaches for enhanced human gene annotation | 000 | 1 | NIH | 12/23/2024 | $387,500 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21EY036948 | Diabetic Retinal Neurodegeneration in Youth Onset Diabetes | 000 | 1 | NIH | 1/27/2025 | $155,000 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21HL172138 | Aortic Valve Calcium Prevalence, Long-term Risk Factors, and progression to Severe Aortic Stenosis Among Persons >75 Years Old | 000 | 1 | NIH | 12/31/2024 | $116,250 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | F31DC022167 | Molecular Mechanisms of Ribbon Synapse Formation in the Inner Ear | 000 | 1 | NIH | 12/6/2024 | $48,974 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R35GM156573 | Mechanistic studies of protein kinases | 000 | 1 | NIH | 12/31/2024 | $387,500 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R03HL176624 | Lipidomics of Pulmonary Vascular Disease | 001 | 1 | NIH | 1/23/2025 | -$122,813 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R03HL176624 | Lipidomics of Pulmonary Vascular Disease | 001 | 1 | NIH | 1/23/2025 | $122,813 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R03HL176624 | Lipidomics of Pulmonary Vascular Disease | 000 | 1 | NIH | 1/17/2025 | $122,813 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R21AI188438 | Insights into the origin of ACPAs in RA | 000 | 1 | NIH | 1/9/2025 | $187,938 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DA060630 | Microglia-mediated adverse effect of cannabis on prefrontal cortex maturation and cognitive function | 000 | 1 | NIH | 12/27/2024 | $656,121 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R00GM151485 | The functional and adaptive roles of RNA recoding | 000 | 3 | NIH | 11/26/2024 | $249,000 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA292812 | Cancer Genetics of Long Telomere Syndromes | 000 | 1 | NIH | 3/10/2025 | $635,033 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01CA299421 | Improving Management of patients at High Risk of Pancreatic Cancer | 000 | 1 | NIH | 2/24/2025 | $653,819 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01MH135896 | Identification and Validation of Epigenetic Biomarkers of PMDD | 000 | 1 | NIH | 12/20/2024 | $641,263 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R01DK138195 | Defining the role of PLA2G12B on apoB-containing lipoprotein assembly, plasma levels, metabolism and cardiovascular disease risk | 000 | 1 | NIH | 3/10/2025 | $603,632 |
| | 2025 | 2025 | THE JOHNS HOPKINS UNIVERSITY | 3400 N CHARLES ST | BALTIMORE | MD | 21218-2608 | BALTIMORE CITY | USA | R00GM143481 | Reconstructing and deconstructing intracellular signaling at the membrane-cytosol interface | 000 | 3 | NIH | 3/5/2025 | $249,000 |
|
